'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response

Acta Psychiatr Scand. 2017 Nov;136(5):526-527. doi: 10.1111/acps.12795. Epub 2017 Aug 28.

B H Ebdrup¹, P L Ishøy¹, B Fagerlund^{1

2}, B V Broberg¹, N Bak¹, F K Knop^{2

3

4}, B Y Glenthøj^{1

2}

¹ Center for Neuropsychiatric Schizophrenia Research (CNSR), Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
² Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
³ Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
⁴ The Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

No abstract available

Publication types